RE: Seen It All Before9 Jul 2021 11:28
If you are thinking of just the UK market then I may be more inclined to agree with you Wadogara but looking at the European, USA and rest of the world scale then I think you are wrong. We in the UK are fortunate to have a full vaccine programme rolled out very quickly. What about the needs of other countries where the vaccine roll out has not ben so quick? Personally, I am looking at a long term picture of world wide customers and not the UK. I think we all agree that the UK has not been kind to any of the diagnostic industries to say the least. I have been here for well over a year and at first it was for a quick splash and dash for the antibody test. Then I realised it could be much more than that so I put more in and just left it. I have been very much involved with the rollercoaster ride we have seen and many times wondered if I had backed the wrong horse but I am still here. I am just below my average and can afford to lose the money if it came to that but I don't think it will. This RNS has given me more confidence about the meeting on the 13th as I am very nervous about what there is to be said and where the share price will go. I didn't think it would go much lower than 60p given all the other parts to Omega but then you can look back and see that in 18 months the share price has increased ten fold.
I really don't know what to expect but my money is in here until I get a definitive answer and I can move on or stay here.
For the record, I think this is a winner.